Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when inclisiran will be available on the NHS to reduce high cholesterol.

Inclisiran, is a twice-yearly injection to help lower cholesterol. As with any other medicine, it will be subject to all usual approval processes including the European Medicines Agency (EMA), the Medicines and Healthcare products Regulatory Agency and the National Institute for Health and Care Excellence before it becomes available on the National Health Service. Inclisiran is currently in Phase III development for secondary prevention patients with expected EMA regulatory filing in Q1 2020.